HQL
abrdn Life Sciences Investors
HQL
HQL
44 hedge funds and large institutions have $47.7M invested in abrdn Life Sciences Investors in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.4% less ownership
Funds ownership: 16.27% → 15.87% (-0.4%)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$731K | |
| 2 | +$593K | |
| 3 | +$593K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$542K |
| 5 |
NEPWA
New England Private Wealth Advisors
Wellesley,
Massachusetts
|
+$344K |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$483K | |
| 3 | -$412K | |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$69.7K |
| 5 |
LPL Financial
San Diego,
California
|
-$55.5K |